Chinese herbal extract granules combined with 5-aminosalicylic acid for patients with moderately active ulcerative colitis: study protocol for a multicenter randomized double-blind placebo-controlled trial
Abstract Background Ulcerative colitis (UC) is an intestinal inflammatory disease characterized by inflammation of the colonic mucosa. With unknown pathogenesis, it has become a chronic lifetime disorder worldwide. In patients with moderately active UC, several therapies (e.g., aminosalicylates, cor...
Main Authors: | Zhaofeng Shen, Kai Zheng, Jiandong Zou, Peiqing Gu, Jing Xing, Lu Zhang, Lei Zhu, Hong Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-020-05012-8 |
Similar Items
-
USE OF 5-AMINOSALICYLIC ACID FOR TREATMENT OF ULCERATIVE COLITIS IN DIFFERENT DOSAGE MODES
by: M. V. Shapina, et al.
Published: (2017-11-01) -
5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis
by: Jun Miyoshi, et al.
Published: (2018-10-01) -
5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis
by: Shinta Mizuno, et al.
Published: (2020-01-01) -
Synthesis and evaluation of a prodrug of 5-aminosalicylic acid for the treatment of ulcerative colitis
by: Yan Yan, et al.
Published: (2019-12-01) -
Aminosalicylates in inflammatory bowel disease
by: Vojislav N. Perisic
Published: (2013-10-01)